Compare TRX & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRX | CLPT |
|---|---|---|
| Founded | 1990 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.0M | 494.6M |
| IPO Year | 2002 | 2009 |
| Metric | TRX | CLPT |
|---|---|---|
| Price | $1.36 | $9.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.70 | ★ $22.50 |
| AVG Volume (30 Days) | ★ 4.5M | 1.0M |
| Earning Date | 04-13-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $73.52 | $48.43 |
| Revenue Next Year | $109.74 | $23.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $0.27 | $8.63 |
| 52 Week High | $2.80 | $30.10 |
| Indicator | TRX | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 38.63 |
| Support Level | $0.32 | $8.63 |
| Resistance Level | $1.95 | $11.74 |
| Average True Range (ATR) | 0.12 | 0.76 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 15.54 | 20.10 |
TRX Gold Corp is engaged in the exploration, development, and production of mineral property interests in the United Republic of Tanzania, focused on development and mining operations, and on exploring and evaluating its mineral properties. The business of exploring and mining for minerals involves a high degree of risk, and the underlying value of the mineral properties depends on the existence and economic recovery of mineral resources and reserves, as well as the ability to raise long-term financing to continue development. The company is focused on the Buckreef Gold Project, which comprises five prospects: Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba, and includes three main mineralized zones: Buckreef South, Buckreef Main, and Buckreef North.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.